Literature DB >> 33437557

Correlates of Residual Thrombus Burden in Successfully Thrombolysed Patients of ST-Elevation Myocardial Infarction Receiving Dual Anti-Platelet Therapy.

Parminder S Otaal1, Abhinav Anand2, Rajesh Vijayvergiya1.   

Abstract

Background Variable residual thrombus ranging from minimal to a large thrombus is seen in the culprit vessel after successful thrombolysis in ST-elevation myocardial infarction (STEMI). Factors associated with residual thrombus in thrombolysed patients are poorly understood. The objective of our study was to determine the correlates of residual thrombus burden in successfully thrombolysed STEMI patients receiving dual antiplatelet therapy. Methods In this prospective observational study of 60 successfully thrombolysed STEMI patients receiving dual antiplatelet therapy, various clinical and coronary angiographic features like residual thrombus burden, residual stenosis, and thrombolysis in myocardial infarction (TIMI) flow grade in the infarct-related artery were evaluated. Results Out of 60 patients, 49 and 11 patients, respectively, had low and high thrombus burden. Thirty-seven (75.5%) patients amongst low-grade thrombus had TIMI 3 flow, whereas seven (63.6%) amongst high thrombus burden had TIMI 2 flow indicating an association between residual thrombus burden and TIMI flow grade, which was statistically significant (p=0.009). Further, amongst the 39 patients who were 45 years old, a statistically significant association of age and residual stenosis (p = 0.039) was observed. Conclusion In successfully thrombolysed STEMI patients receiving dual antiplatelet therapy, there is an inverse correlation between residual thrombus burden and TIMI flow grade with high-grade residual thrombus associated with more frequent low TIMI flow. Further, significant residual stenosis is more common in patients older than 45 years of age, underscoring the necessity for invasive evaluation after successful thrombolysis.
Copyright © 2020, Otaal et al.

Entities:  

Keywords:  dual antiplatelet therapy; residual thrombus burden; stemi; thrombolysis

Year:  2020        PMID: 33437557      PMCID: PMC7793332          DOI: 10.7759/cureus.12017

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  21 in total

1.  Coronary heart disease and risk factors in India - on the brink of an epidemic?

Authors:  M N Krishnan
Journal:  Indian Heart J       Date:  2012-07-13

2.  Degree of residual stenosis in the culprit coronary artery after thrombolytic administration (Thrombolysis In Myocardial Infarction [TIMI] trials).

Authors:  J Llevadot; R P Giugliano; C H McCabe; C P Cannon; E M Antman; S Murphy; C M Gibson
Journal:  Am J Cardiol       Date:  2000-06-15       Impact factor: 2.778

3.  The role of residual intrastent thrombus during primary angioplasty: insights from the COCTAIL II study.

Authors:  Laura Gatto; Enrico Romagnoli; Francesco Versaci; Ugo Limbruno; Tomasz Pawlowski; Italo Porto; Valeria Marco; Luca Di Vito; Fabrizio Imola; Alberto Cremonesi; Francesco Prati
Journal:  J Cardiovasc Med (Hagerstown)       Date:  2017-05       Impact factor: 2.160

4.  Clinical value of 12-lead electrocardiogram after successful reperfusion therapy for acute myocardial infarction. Zwolle Myocardial infarction Study Group.

Authors:  A W van 't Hof; A Liem; M J de Boer; F Zijlstra
Journal:  Lancet       Date:  1997-08-30       Impact factor: 79.321

5.  The impact of initial and residual thrombus burden on the no-reflow phenomenon in patients with ST-segment elevation myocardial infarction.

Authors:  Sung Gyun Ahn; Hyun-Hee Choi; Ji Hyun Lee; Jun-Won Lee; Young Jin Youn; Sang-Yong Yoo; Byung Ryul Cho; Seung-Hwan Lee; Junghan Yoon
Journal:  Coron Artery Dis       Date:  2015-05       Impact factor: 1.439

6.  Myocardial infarction in young adults: angiographic characterization, risk factors and prognosis (Coronary Artery Surgery Study Registry).

Authors:  F H Zimmerman; A Cameron; L D Fisher; G Ng
Journal:  J Am Coll Cardiol       Date:  1995-09       Impact factor: 24.094

7.  Determinants of angiographic thrombus burden in patients with ST-segment elevation myocardial infarction.

Authors:  Ibrahim Halil Tanboga; Selim Topcu; Enbiya Aksakal; Kamuran Kalkan; Serdar Sevimli; Mahmut Acikel
Journal:  Clin Appl Thromb Hemost       Date:  2013-03-27       Impact factor: 2.389

8.  Bilirubin Levels and Thrombus Burden in Patients With ST-Segment Elevation Myocardial Infarction.

Authors:  Hikmet Hamur; Hakan Duman; Eftal Murat Bakirci; Zafer Kucuksu; Selami Demirelli; Kamuran Kalkan; Husnu Degirmenci
Journal:  Angiology       Date:  2015-09-02       Impact factor: 3.619

9.  Relation of angiographic thrombus burden with electrocardiographic grade III ischemia in patients with ST-segment elevation myocardial infarction.

Authors:  Mustafa Kurt; Mehmet Fatih Karakas; Eyup Buyukkaya; Adnan Burak Akçay; Nihat Sen
Journal:  Clin Appl Thromb Hemost       Date:  2013-02-12       Impact factor: 2.389

Review 10.  Aspiration thrombectomy prior to percutaneous coronary intervention in ST-elevation myocardial infarction: a systematic review and meta-analysis.

Authors:  Regina El Dib; Frederick Alan Spencer; Erica Aranha Suzumura; Huda Gomaa; Joey Kwong; Gordon Henry Guyatt; Per Olav Vandvik
Journal:  BMC Cardiovasc Disord       Date:  2016-06-02       Impact factor: 2.298

View more
  1 in total

1.  Systemic Immune-Inflammation Index: A Novel Predictor of Coronary Thrombus Burden in Patients with Non-ST Acute Coronary Syndrome.

Authors:  Uğur Özkan; Muhammet Gürdoğan; Cihan Öztürk; Melik Demir; Ömer Feridun Akkuş; Efe Yılmaz; Servet Altay
Journal:  Medicina (Kaunas)       Date:  2022-01-18       Impact factor: 2.430

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.